Lipotoxic heart disease in obese rats: Implications for human obesity
AUTOR(ES)
Zhou, Yan-Ting
FONTE
The National Academy of Sciences
RESUMO
To determine the mechanism of the cardiac dilatation and reduced contractility of obese Zucker Diabetic Fatty rats, myocardial triacylglycerol (TG) was assayed chemically and morphologically. TG was high because of underexpression of fatty acid oxidative enzymes and their transcription factor, peroxisome proliferator-activated receptor-α. Levels of ceramide, a mediator of apoptosis, were 2–3 times those of controls and inducible nitric oxide synthase levels were 4 times greater than normal. Myocardial DNA laddering, an index of apoptosis, reached 20 times the normal level. Troglitazone therapy lowered myocardial TG and ceramide and completely prevented DNA laddering and loss of cardiac function. In this paper, we conclude that cardiac dysfunction in obesity is caused by lipoapoptosis and is prevented by reducing cardiac lipids.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=26513Documentos Relacionados
- Noninvasive method for electrocardiogram recording in conscious rats: feasibility for heart rate variability analysis
- Induction of an antigen specific gut inflammatory reaction in mice and rats: a model for human Inflammatory Bowel Disease
- Chronic heart failure modifies respiratory mechanics in rats: a randomized controlled trial
- Anti-obesity and hepatoprotective effects in obese rats fed diets supplemented with fruit purees
- Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance